1. P2Y12 inhibition by clopidogrel increases adverse clinical outcomes in patients undergoing transcatheter aortic valve replacement. (25th November 2020) Authors: Matsushita, K; Marchandot, B; Kibler, M; Sato, C; Heger, J; Peillex, M; Trimaille, A; Hess, S; Grunebaum, L; Ohana, M; Reydel, A; Jesel, L; Ohlmann, P; Morel, O Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Predictive impact of PVL assessments on clinical outcomes in patients undergoing TAVR. (25th November 2020) Authors: Matsushita, K; Marchandot, B; Kibler, M; Sato, C; Heger, J; Peillex, M; Trimaille, A; Hess, S; Grunebaum, L; Ohana, M; Reydel, A; Jesel, L; Ohlmann, P; Morel, O Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Residual inflammation is a major determinant of myocardial recovery and cardiovascular outcome in takotsubo patients. (25th November 2020) Authors: Lachmet-Thebaud, L; Marchandot, B; Matsushita, K; Sato, C; Dagrenat, C; Greciano, S; De Poli, F; Leddet, P; Peillex, M; Hess, S; Carmona, A; Reydel, A; Ohlmann, P; Jesel, L; Morel, O Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗